General Nieuws Oxurion Receives EUR 1.0 Million under Amended Atlas Funding Program Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Reach Topline Data from KALAHARI Trial This Year EN november 16, 2023
General Nieuws Oxurion Receives EUR 1.5 Million under Amended Atlas Funding Program; Total of EUR 3.5 Million in Unconditional Funding Allowing Company to Achieve Topline Data from KALAHARI Trial EN oktober 25, 2023
General Nieuws Oxurion Receives First EUR 1 Million under Amended Atlas Funding Program EN september 18, 2023
General Nieuws Oxurion Receives Funding of EUR One Million under Atlas Special Opportunities LLC (Atlas) Funding Program EN augustus 11, 2023
General Nieuws Oxurion Receives Upfront Payment of $400,000 Following Oncurious Asset License by VIB EN juli 25, 2023
General Nieuws Oxurion Issues EUR 1.0 million in Bonds for Tranche 3 of the Funding Program with Atlas Special Opportunities LLC EN juni 15, 2023
General Nieuws Oxurion Finalizes Enrollment in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema EN juni 12, 2023
General Nieuws Regulated Oxurion Reaches Enrollment Target in KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema EN mei 25, 2023
General Nieuws Oxurion Issues EUR 2.0 million in Bonds for Tranche 2 of the Funding Program with Atlas Special Opportunities LLC EN mei 22, 2023
General Nieuws Regulated Oxurion Announces Results of the Annual Shareholders’ Meeting of 2 May 2023 EN mei 15, 2023
General Nieuws Oxurion Issues EUR 2.0 million in Bonds for Tranche 1 (B) of the Funding Program with Atlas Special Opportunities LLC EN april 27, 2023
General Nieuws Oxurion Issues EUR 2.8 million in Bonds for Tranche 1 (A) of Funding Program with Atlas Special Opportunities LL EN maart 20, 2023
General Nieuws Oxurion Provides Update on Recruitment for KALAHARI Phase 2, Part B Trial of Novel PKal Inhibitor THR-149 in Diabetic Macular Edema and Announces Board Changes EN maart 14, 2023
General Nieuws Regulated Oxurion Announces Subscription Agreement with Atlas Providing the Company with Up To €20 Million in Funding EN maart 2, 2023
General Nieuws Oxurion Provides Further Details Concerning the Second Amendment to Negma Funding Program EN januari 27, 2023
General Nieuws Regulated Oxurion Announces Second Amendment to Negma Funding Program EN januari 25, 2023
